Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | 65.29%27.75M | 65.29%27.75M | -32.49%16.79M | -32.49%16.79M | 5.46%24.87M | 5.46%24.87M | -50.11%23.58M | -50.11%23.58M | 150.85%47.26M | 150.85%47.26M |
| -Cash and cash equivalents | 65.29%27.75M | 65.29%27.75M | -32.49%16.79M | -32.49%16.79M | 5.46%24.87M | 5.46%24.87M | -50.11%23.58M | -50.11%23.58M | 150.85%47.26M | 150.85%47.26M |
| Long term equity investment | 3.79%44.64M | 3.79%44.64M | 120.89%43.01M | 120.89%43.01M | -45.49%19.47M | -45.49%19.47M | -42.05%35.72M | -42.05%35.72M | -1.84%61.64M | -1.84%61.64M |
| Receivables | -25.32%118K | -25.32%118K | 14.49%158K | 14.49%158K | -34.29%138K | -34.29%138K | 262.07%210K | 262.07%210K | -22.67%58K | -22.67%58K |
| -Accounts receivable | 48.53%101K | 48.53%101K | 100.00%68K | 100.00%68K | -17.07%34K | -17.07%34K | 7.89%41K | 7.89%41K | -38.71%38K | -38.71%38K |
| -Other receivables | -81.11%17K | -81.11%17K | -13.46%90K | -13.46%90K | -38.46%104K | -38.46%104K | 745.00%169K | 745.00%169K | 53.85%20K | 53.85%20K |
| Deferred assets | -21.88%1.64M | -21.88%1.64M | 1.80%2.09M | 1.80%2.09M | -10.84%2.06M | -10.84%2.06M | 653.59%2.31M | 653.59%2.31M | -80.95%306K | -80.95%306K |
| Total assets | 19.49%74.14M | 19.49%74.14M | 33.35%62.05M | 33.35%62.05M | -24.73%46.53M | -24.73%46.53M | -43.42%61.82M | -43.42%61.82M | 31.14%109.26M | 31.14%109.26M |
| Liabilities | ||||||||||
| Current debt and capital lease obligation | 16.06%28.84M | 16.06%28.84M | 75.42%24.85M | 75.42%24.85M | -28.24%14.17M | -28.24%14.17M | -57.27%19.74M | -57.27%19.74M | 34.12%46.2M | 34.12%46.2M |
| -Current debt | 16.06%28.84M | 16.06%28.84M | 75.42%24.85M | 75.42%24.85M | -28.24%14.17M | -28.24%14.17M | -57.27%19.74M | -57.27%19.74M | 34.12%46.2M | 34.12%46.2M |
| Payables | 196.12%687K | 196.12%687K | 7.91%232K | 7.91%232K | -3.59%215K | -3.59%215K | -49.77%223K | -49.77%223K | 246.88%444K | 246.88%444K |
| -Accounts payable | 196.12%687K | 196.12%687K | 7.91%232K | 7.91%232K | -3.59%215K | -3.59%215K | -49.77%223K | -49.77%223K | 246.88%444K | 246.88%444K |
| Current deferred liabilities | --1.18M | --1.18M | ---- | ---- | ---- | ---- | ---- | ---- | --1.79M | --1.79M |
| Non current deferred liabilities | 90.40%3.71M | 90.40%3.71M | 19,380.00%1.95M | 19,380.00%1.95M | -92.81%10K | -92.81%10K | -95.07%139K | -95.07%139K | 62.27%2.82M | 62.27%2.82M |
| Total liabilities | 27.32%34.42M | 27.32%34.42M | 87.83%27.03M | 87.83%27.03M | -28.42%14.39M | -28.42%14.39M | -60.77%20.11M | -60.77%20.11M | 41.13%51.25M | 41.13%51.25M |
| Shareholders'equity | ||||||||||
| Share capital | -3.29%32.51M | -3.29%32.51M | -4.52%33.62M | -4.52%33.62M | -20.43%35.21M | -20.43%35.21M | -8.26%44.25M | -8.26%44.25M | 5.00%48.23M | 5.00%48.23M |
| -common stock | -3.29%32.51M | -3.29%32.51M | -4.52%33.62M | -4.52%33.62M | -20.43%35.21M | -20.43%35.21M | -8.26%44.25M | -8.26%44.25M | 5.00%48.23M | 5.00%48.23M |
| Retained earnings | 421.99%7.19M | 421.99%7.19M | 144.55%1.38M | 144.55%1.38M | -20.87%-3.09M | -20.87%-3.09M | -126.22%-2.56M | -126.22%-2.56M | 811.39%9.76M | 811.39%9.76M |
| Gains losses not affecting retained earnings | 0.00%20K | 0.00%20K | 0.00%20K | 0.00%20K | 0.00%20K | 0.00%20K | 0.00%20K | 0.00%20K | --20K | --20K |
| Total stockholders'equity | 13.45%39.73M | 13.45%39.73M | 8.96%35.02M | 8.96%35.02M | -22.95%32.14M | -22.95%32.14M | -28.10%41.71M | -28.10%41.71M | 23.42%58.01M | 23.42%58.01M |
| Total equity | 13.45%39.73M | 13.45%39.73M | 8.96%35.02M | 8.96%35.02M | -22.95%32.14M | -22.95%32.14M | -28.10%41.71M | -28.10%41.71M | 23.42%58.01M | 23.42%58.01M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |